Literature DB >> 17185438

New combination vaccines still need a boost.

A J Pollard1.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17185438      PMCID: PMC2083155          DOI: 10.1136/adc.2006.106724

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  17 in total

Review 1.  Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis.

Authors:  J Eskola; J Ward; R Dagan; D Goldblatt; F Zepp; C A Siegrist
Journal:  Lancet       Date:  1999-12-11       Impact factor: 79.321

Review 2.  Systematic review of the effects of pertussis vaccines in children.

Authors:  Tom Jefferson; Melanie Rudin; Carlo DiPietrantonj
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

3.  Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis.

Authors:  J McVernon; N Andrews; M P E Slack; M E Ramsay
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

Review 4.  Acellular vaccines for preventing whooping cough in children.

Authors:  O N Tinnion; M Hanlon
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age.

Authors:  N R E Kitchin; J Southern; R Morris; F Hemme; S Thomas; M W Watson; K Cartwright; E Miller
Journal:  Arch Dis Child       Date:  2006-05-02       Impact factor: 3.791

6.  Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines.

Authors:  P Olin; F Rasmussen; L Gustafsson; H O Hallander; H Heijbel
Journal:  Lancet       Date:  1997-11-29       Impact factor: 79.321

7.  Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT.

Authors:  Nicole Le Saux; Nicholas J Barrowman; Dorothy L Moore; Sharon Whiting; David Scheifele; Scott Halperin
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

8.  Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.

Authors:  Caroline L Trotter; Nick J Andrews; Edward B Kaczmarski; Elizabeth Miller; Mary E Ramsay
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

9.  Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.

Authors:  Scott A Halperin; Jane McDonald; Lindy Samson; Lisa Danzig; George Santos; Allen Izu; Bruce Smith; Noni MacDonald
Journal:  Clin Invest Med       Date:  2002-12       Impact factor: 0.825

10.  A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.

Authors:  D Greco; S Salmaso; P Mastrantonio; M Giuliano; A E Tozzi; A Anemona; M L Ciofi degli Atti; A Giammanco; P Panei; W C Blackwelder; D L Klein; S G Wassilak
Journal:  N Engl J Med       Date:  1996-02-08       Impact factor: 91.245

View more
  1 in total

1.  Update on available vaccines in India: report of the APPA VU 2010: I.

Authors:  Sunil Karande
Journal:  Indian J Pediatr       Date:  2011-03-05       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.